Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk prostate cancer

OBJECTIVE: The addition of androgen deprivation therapy (ADT) to conventional radiation therapy improves overall survival (OS) in intermediate- and high-risk prostate cancer. The benefit of ADT to added to dose-escalated radiotherapy is less clear. The aim of this study was to report disease control...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadia, Rafael, Teixeira Leite, Elton Trigo, Bierrenbach, Ana Luiza, Ynoe de Moraes, Fabio, Spratt, Daniel E., Arruda, Fernando Freire, Cintra Vita Abreu, Carlos Eduardo, Fernandes da Silva, Joao Luis, de Andrade Carvalho, Heloisa, Garicochea, Bernardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514229/
https://www.ncbi.nlm.nih.gov/pubmed/28740901
http://dx.doi.org/10.1016/j.adro.2016.10.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514229/
https://www.ncbi.nlm.nih.gov/pubmed/28740901
http://dx.doi.org/10.1016/j.adro.2016.10.006

Ejemplares similares